De Burlo Group’s Amedisys AMED Stock Holding History

De Burlo Group’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-50	Closed	-$4.84K	–	86
2022 Q3	$4.84K	Buy	+50	New	+$5.96K	﹤0.01%	164
2022 Q2	–	Sell	-50	Closed	-$8.61K	–	91
2022 Q1	$8.61K	Buy	+50	New	+$7.47K	﹤0.01%	149
2019 Q1	–	Sell	-38,450	Closed	-$4.5M	–	94
2018 Q4	$4.5M	Sell	38,450 -14,800	-28%	-$1.74M	1.01%	31
2018 Q3	$6.65M	Sell	53,250 -27,400	-34%	-$3.03M	1.25%	32
2018 Q2	$6.89M	Buy	+80,650	New	+$5.92M	1.46%	24

Other funds holding AMED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

De Burlo Group's AMED Position: Q4 2022 in Review

De Burlo Group sold out of Amedisys (AMED) in Q4 2022, closing a stake of 50 shares — an estimated $4.84K sold.

De Burlo Group first reported a position in AMED in Q2 2018 and held it in 5 quarters. The position peaked at $6.89M in Q2 2018. 277 funds tracked by Wall St. Rank hold AMED as of Q4 2022.

De Burlo Group reported no remaining Amedisys position as of Q4 2022 after selling out during the quarter.
De Burlo Group sold 50 Amedisys shares in Q4 2022, an estimated $4.84K.
De Burlo Group first reported a position in Amedisys in Q2 2018 and held it in 5 quarters.
De Burlo Group's Amedisys position peaked at $6.89M in Q2 2018.
277 funds tracked by Wall St. Rank held Amedisys as of Q4 2022.

Based on De Burlo Group's 13F filing for Q4 2022, filed 14 Feb 2023.